Pages that link to "Q28475948"
Jump to navigation
Jump to search
The following pages link to A nanoconjugate Apaf-1 inhibitor protects mesothelial cells from cytokine-induced injury (Q28475948):
Displaying 13 items.
- TWEAK and the progression of renal disease: clinical translation (Q26996775) (← links)
- TWEAK promotes peritoneal inflammation (Q27318227) (← links)
- A polymeric nanomedicine diminishes inflammatory events in renal tubular cells (Q34542058) (← links)
- Molecules that modulate Apaf-1 activity (Q37680800) (← links)
- Cell death assays for drug discovery (Q37848054) (← links)
- Polymer therapeutics as nanomedicines: new perspectives (Q37890109) (← links)
- Progress in the development of animal models of acute kidney injury and its impact on drug discovery (Q38102743) (← links)
- Designing drugs that combat kidney damage. (Q38404587) (← links)
- Smart branched polymer drug conjugates as nano-sized drug delivery systems (Q38565174) (← links)
- Apaf1 inhibition promotes cell recovery from apoptosis. (Q38836005) (← links)
- Nanomedicines for kidney diseases (Q38862723) (← links)
- Interleukin-1 receptor-mediated inflammation impairs the heat shock response of human mesothelial cells. (Q41901427) (← links)
- Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease (Q48948068) (← links)